282 related articles for article (PubMed ID: 34944056)
1. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
Yu H; Liu X; Chen B; Vickstrom CR; Friedman V; Kelly TJ; Bai X; Zhao L; Hillard CJ; Liu QS
Cells; 2021 Dec; 10(12):. PubMed ID: 34944056
[TBL] [Abstract][Full Text] [Related]
2. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
Stayte S; Rentsch P; Li KM; Vissel B
PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
[TBL] [Abstract][Full Text] [Related]
3. CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice.
Liu X; Yu H; Chen B; Friedman V; Mu L; Kelly TJ; Ruiz-Pérez G; Zhao L; Bai X; Hillard CJ; Liu QS
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892676
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
[TBL] [Abstract][Full Text] [Related]
5. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
Burgaz S; García C; Gómez-Cañas M; Navarrete C; García-Martín A; Rolland A; Del Río C; Casarejos MJ; Muñoz E; Gonzalo-Consuegra C; Muñoz E; Fernández-Ruiz J
Mol Cell Neurosci; 2021 Jan; 110():103583. PubMed ID: 33338634
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.
Lazzarini M; Martin S; Mitkovski M; Vozari RR; Stühmer W; Bel ED
Glia; 2013 Jul; 61(7):1084-100. PubMed ID: 23595698
[TBL] [Abstract][Full Text] [Related]
11. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
[TBL] [Abstract][Full Text] [Related]
12. CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.
Chung YC; Shin WH; Baek JY; Cho EJ; Baik HH; Kim SR; Won SY; Jin BK
Exp Mol Med; 2016 Jan; 48(1):e205. PubMed ID: 27534533
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease.
Giuliano C; Siani F; Mus L; Ghezzi C; Cerri S; Pacchetti B; Bigogno C; Blandini F
Nutrition; 2020 Jan; 69():110494. PubMed ID: 31586482
[TBL] [Abstract][Full Text] [Related]
14. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
[TBL] [Abstract][Full Text] [Related]
15. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease.
Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS
J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406
[TBL] [Abstract][Full Text] [Related]
16. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
18. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
García C; Palomo-Garo C; García-Arencibia M; Ramos J; Pertwee R; Fernández-Ruiz J
Br J Pharmacol; 2011 Aug; 163(7):1495-506. PubMed ID: 21323909
[TBL] [Abstract][Full Text] [Related]
19. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Fletcher EJR; Moon LDF; Duty S
BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.
Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
